E1 ReplicatedModerate confidencePEM not requiredRCTPeer-reviewedReviewed
Standard · 3 min
Therapist Effects and the Impact of Early Therapeutic Alliance on Symptomatic Outcome in Chronic Fatigue Syndrome.
Goldsmith, Lucy P, Dunn, Graham, Bentall, Richard P et al. · PloS one · 2015 · DOI
Quick Summary
This study looked at whether the quality of the relationship between therapist and patient affects how well two different talking therapies work for ME/CFS. Researchers tracked 296 patients who received either a home-based rehabilitation program, counselling support, or standard care, and measured how well patients improved. They found that the therapist you saw did not make a difference in treatment outcomes, and the strength of the relationship between therapist and patient did not predict who got better.
Why It Matters
This study is important because it rigorously examines whether the 'human element' of therapy—the relationship between patient and therapist—drives treatment success in ME/CFS. Understanding what actually works in ME/CFS treatment is critical given the complexity of the condition and ongoing debates about psychosocial interventions. These findings suggest that for these particular therapies, standardized treatment protocols may be more important than therapist variation.
Observed Findings
No significant therapist effects were detected across treatment arms, meaning different therapists achieved similar average outcomes.
No relationship was found between strength of therapeutic alliance and treatment effect size.
One therapist formed significantly stronger alliances when delivering PR (d=0.76) compared to SL, despite achieving comparable patient outcomes.
Blind outcome assessment and randomized therapist allocation successfully eliminated potential selection bias present in prior studies.
Both PR and SL were deliverable with consistent quality across multiple therapists in a controlled trial setting.
Inferred Conclusions
Therapeutic alliance does not appear to be a mechanism driving symptomatic improvement in these CFS therapies.
Rigorous quality control, standardized protocols, and randomized therapist allocation may eliminate meaningful therapist effects on outcome.
Therapist variation may be less important than adherence to structured treatment manuals in these particular interventions.
Further research is needed to determine whether these findings generalize to other ME/CFS treatments or other therapeutic approaches.
Remaining Questions
Why did the one therapist form stronger alliances in PR versus SL, and what treatment mechanisms might explain this without affecting outcomes?
What This Study Does Not Prove
This study does not prove that therapeutic alliance is unimportant in all ME/CFS treatments or for all therapies in general—only that it did not predict outcomes in these two specific interventions. It also does not establish that therapist training, competence, or adherence to treatment protocols are unimportant. The findings are specific to PR and SL and may not generalize to other therapeutic approaches.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.